Key result
Reductions in blood pressure and cholesterol between 2000 and 2007 prevented approximately 20,400 deaths, with population-wide changes reducing socioeconomic disparities while statins maintained them.
Why the study?
What is the relative contribution of preventive medications versus population-wide changes in blood pressure and cholesterol to coronary mortality reduction across socioeconomic groups?
What is the relative contribution of preventive medications versus population-wide changes in blood pressure and cholesterol to coronary mortality reduction across socioeconomic groups?
Population-wide reductions in blood pressure and cholesterol substantially reduced CHD mortality and socioeconomic disparities, whereas statin use for high-risk individuals maintained socioeconomic inequalities.
No takes yet. Share an insight, caveat, or question.
Supports population-wide BP/cholesterol reductions to narrow disparities; leaves open whether statin strategies can reduce inequities.
Guzman-Castillo et al. (2015) studied Coronary heart disease. Reductions in blood pressure and cholesterol was evaluated on Number of deaths prevented or postponed (DPPs) in 2007 by socioeconomic status. Reductions in blood pressure and cholesterol between 2000 and 2007 prevented approximately 20,400 deaths, with population-wide changes reducing socioeconomic disparities while statins maintained them.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: